PLoS ONE (Jan 2014)

Treatment of FANCA cells with resveratrol and N-acetylcysteine: a comparative study.

  • Marta Columbaro,
  • Silvia Ravera,
  • Cristina Capanni,
  • Isabella Panfoli,
  • Paola Cuccarolo,
  • Giorgia Stroppiana,
  • Paolo Degan,
  • Enrico Cappelli

DOI
https://doi.org/10.1371/journal.pone.0104857
Journal volume & issue
Vol. 9, no. 7
p. e104857

Abstract

Read online

Fanconi anemia (FA) is a genetic disorder characterised by chromosome instability, cytokine ipersensibility, bone marrow failure and abnormal haematopoiesis associated with acute myelogenous leukemia. Recent reports are contributing to characterize the peculiar FA metabolism. Central to these considerations appears that cells from complementation group A (FANCA) display an altered red-ox metabolism. Consequently the possibility to improve FA phenotypical conditions with antioxidants is considered. We have characterized from the structural and biochemical point of view the response of FANCA lymphocytes to N-acetyl-cysteine (NAC) and resveratrol (RV). Surprisingly both NAC and RV failed to revert all the characteristic of FA phenotype and moreover their effects are not super imposable. Our data suggest that we must be aware of the biological effects coming from antioxidant treatment.